LU86697A1 - Nouveaux derives de la calcitonine,leur preparation et leur utilisation comme medicaments - Google Patents

Nouveaux derives de la calcitonine,leur preparation et leur utilisation comme medicaments Download PDF

Info

Publication number
LU86697A1
LU86697A1 LU86697A LU86697A LU86697A1 LU 86697 A1 LU86697 A1 LU 86697A1 LU 86697 A LU86697 A LU 86697A LU 86697 A LU86697 A LU 86697A LU 86697 A1 LU86697 A1 LU 86697A1
Authority
LU
Luxembourg
Prior art keywords
thr
leu
ser
formula
gly
Prior art date
Application number
LU86697A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU86697A1 publication Critical patent/LU86697A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/585Calcitonins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
LU86697A 1985-12-04 1986-12-03 Nouveaux derives de la calcitonine,leur preparation et leur utilisation comme medicaments LU86697A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3542859 1985-12-04
DE3542859 1985-12-04
DE3614784 1986-05-02
DE3614784 1986-05-02

Publications (1)

Publication Number Publication Date
LU86697A1 true LU86697A1 (fr) 1987-07-24

Family

ID=25838500

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86697A LU86697A1 (fr) 1985-12-04 1986-12-03 Nouveaux derives de la calcitonine,leur preparation et leur utilisation comme medicaments

Country Status (20)

Country Link
US (1) US4758550A (ja)
JP (1) JPH085916B2 (ja)
KR (1) KR880006263A (ja)
AU (1) AU600242B2 (ja)
BE (1) BE905849A (ja)
CH (1) CH671229A5 (ja)
DK (1) DK580186A (ja)
ES (1) ES2012510A6 (ja)
FI (1) FI864939A (ja)
FR (1) FR2590902B1 (ja)
GB (1) GB2184729B (ja)
GR (1) GR862836B (ja)
HU (1) HUT44794A (ja)
IL (1) IL80846A0 (ja)
IT (1) IT1214754B (ja)
LU (1) LU86697A1 (ja)
NL (1) NL8602950A (ja)
NZ (1) NZ218473A (ja)
PT (1) PT83835B (ja)
SE (1) SE8605189L (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2052642T3 (es) * 1987-07-08 1994-07-16 Mitsubishi Petrochemical Co Nuevo derivado de calcitonina y su sal.
AU609911B2 (en) * 1987-12-16 1991-05-09 Rorer International (Overseas) Inc. 8-glycine,16-x, des-19-leucine-calcitonin
GB2218102B (en) * 1988-04-08 1992-09-16 Sandoz Ltd Calcitonin peptide derivatives
US5153308A (en) * 1988-06-16 1992-10-06 Teijin Limited S-sulfonated calcitonin derivatives
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
DE68912090T2 (de) * 1988-11-24 1994-06-16 Mitsubishi Petrochemical Co Calcitonin-Derivate und deren Salze.
WO1990009781A1 (en) * 1989-02-23 1990-09-07 Rorer International (Holdings), Inc. Therapeutic aerosol formulations
US5204326A (en) * 1989-03-16 1993-04-20 Otsuka Pharmaceutical Co., Ltd. Polypeptide derivatives and calcium metabolism improving agent
AU640141B2 (en) * 1989-04-21 1993-08-19 Tsumura & Co. Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient
US5364840A (en) * 1989-12-05 1994-11-15 Vical, Inc. Synthetic calcitonin peptides
US5175146A (en) * 1989-12-05 1992-12-29 Vical, Inc. Synthetic calcitonin peptides
CS89491A3 (en) * 1990-04-09 1992-01-15 Chugai Pharmaceutical Co Ltd Hybrid calcitonin
ES2051647B1 (es) * 1992-12-10 1995-01-16 Lipotec Sa Procedimiento para la preparacion de calcitonina de salmon.
JPH08505393A (ja) * 1992-12-31 1996-06-11 ザイモジェネティクス,インコーポレイティド 誘導体化カルシトニン
US5710244A (en) * 1992-12-31 1998-01-20 Labroo; Virender M. Derivatized calcitonins
AU1919595A (en) * 1994-02-09 1995-08-29 Brigham And Women's Hospital Gel-forming polypeptide derivatives
DE726075T1 (de) * 1995-02-08 1996-12-12 Therapicon Srl Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
KR960031478A (ko) * 1995-02-14 1996-09-17 성재갑 유비퀴틴 융합 인간 칼시토닌의 정제방법
US6034064A (en) * 1995-04-07 2000-03-07 Hoechst Pharmaceuticals & Chemicals K.K. Peptides and therapeutic agent for autoimmune diseases containing the same
US5721207A (en) * 1995-04-18 1998-02-24 Innapharma, Inc. Method for treatment of pain
WO1999040928A1 (en) 1998-02-13 1999-08-19 Amylin Pharmaceuticals, Inc. Novel mixed amylin activity compounds
US6936584B1 (en) 1998-02-13 2005-08-30 Amylin Pharmaceuticals, Inc. Mixed amylin activity compounds
BRPI0708299A2 (pt) * 2006-02-27 2011-05-24 Univ Leland Stanford Junior composições e métodos para o transporte de moléculas com propriedades melhoradas de liberação através de barreiras biológicas
BR112014013697A2 (pt) * 2011-12-09 2020-11-03 The Regents Of The University Of California peptídeos mini-hepcidina modificados e métodos de uso dos mesmos
US9816066B2 (en) 2012-04-24 2017-11-14 The Regents Of The University Of California Method for delivery of small molecules and proteins across the cell wall of algae using molecular transporters

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3926938A (en) * 1974-08-12 1975-12-16 Armour Pharma Synthesis of salmon calcitonin
JPS51128993A (en) * 1975-05-01 1976-11-10 Tanpakushitsu Kenkyu Shiyoureikai Process for preparing new polypeptides
GB1592969A (en) * 1976-09-13 1981-07-15 Armour Pharma Hentriacontapeptides and preparation thereof
JPS60500054A (ja) * 1983-02-15 1985-01-17 ア−マ−・フア−マシユ−テイカル・カンパニ− デス−アスパラギン−3−カルシトニン
US4663309A (en) * 1983-06-29 1987-05-05 University Patents, Inc. Novel peptide hormones with calcitonin-like activity
GB8327346D0 (en) * 1983-10-12 1983-11-16 Morris H R Peptide
US4497732A (en) * 1983-10-21 1985-02-05 Armour Pharmaceutical Company 1A-Endo-glycine-calcitonin
US4537716A (en) * 1983-12-05 1985-08-27 Armour Pharmaceutical Co. Des-serine2 or des-glycine2 -leucine22 calcitonin
US4622386A (en) * 1985-03-28 1986-11-11 Armour Pharmaceutical Company [1,7-di-alanine]calcitonin
US4658014A (en) * 1985-12-20 1987-04-14 Kempe Tomas G Synthetic peptides with calcitonin-like activity
AU7468687A (en) * 1987-06-23 1989-01-05 Armour Pharmaceutical Company (n-acyl, 1,7-di-alanine) calcitonin

Also Published As

Publication number Publication date
FI864939A0 (fi) 1986-12-03
DK580186D0 (da) 1986-12-02
SE8605189D0 (sv) 1986-12-03
IT8648701A0 (it) 1986-12-04
IL80846A0 (en) 1987-03-31
JPS62132898A (ja) 1987-06-16
DK580186A (da) 1987-06-05
FI864939A (fi) 1987-06-05
GB2184729A (en) 1987-07-01
GB8628739D0 (en) 1987-01-07
GR862836B (en) 1987-04-02
FR2590902A1 (fr) 1987-06-05
IT1214754B (it) 1990-01-18
PT83835A (en) 1986-12-01
HUT44794A (en) 1988-04-28
JPH085916B2 (ja) 1996-01-24
SE8605189L (sv) 1987-06-05
AU6606186A (en) 1987-06-11
PT83835B (pt) 1989-06-30
GB2184729B (en) 1990-07-25
NL8602950A (nl) 1987-07-01
NZ218473A (en) 1990-03-27
US4758550A (en) 1988-07-19
AU600242B2 (en) 1990-08-09
BE905849A (fr) 1987-06-03
FR2590902B1 (fr) 1994-12-23
KR880006263A (ko) 1988-07-22
CH671229A5 (ja) 1989-08-15
ES2012510A6 (es) 1990-04-01

Similar Documents

Publication Publication Date Title
LU86697A1 (fr) Nouveaux derives de la calcitonine,leur preparation et leur utilisation comme medicaments
BE1003752A4 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
BE1004357A4 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
KR850000415B1 (ko) 아실펩타이드의 제조방법
CS228140B2 (en) Production of straight or monocyclic polypeptides
US7482429B2 (en) Kahalalide F and related compounds
JPH05508406A (ja) 新規保護インスリン類似体
FR2501199A1 (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
EP0676411A2 (fr) Peptides et pseudopeptides dérivés de tachykinines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0187095B1 (fr) Esters de tri- et tétrapeptides inhibiteurs de la sécrétion gastrique, procédé d'obtention et compositions pharmaceutiques les contenant
EP1246837A2 (fr) Oligomeres de mimes contraints non peptidiques de dipeptides ou de tripeptides, et leur utilisation pour la synthese de proteines et polypeptides artificiels
EP0283956B1 (en) Fluorine containing atrial natriuretic peptides
CA1249100A (fr) Derives peptidiques, leur procede de preparation et les compositions les contenant
FR2522655A1 (fr) Analogues de la somatostatine possedant une liaison du type hydrazide et medicaments en contenant
BE897546A (fr) Nouveaux polypeptides leur preparation et leur application comme medicaments
EP0188947B1 (fr) Peptides réduits, inhibiteurs de la sécrétion gastrique, procédé d'obtention et compositions pharmaceutiques les contenant
EP0948524A1 (fr) Peptides agonistes du recepteur b 2? de la bradykinine
EP0117447A1 (de) Cyclische Peptide mit Somatostatin-Wirkung
CH616652A5 (ja)
FR2564844A1 (fr) Nouveaux peptides derives de la statine, procede d'obtention et compositions pharmaceutiques les contenant
EP0115227B1 (fr) Nouveaux dérivés peptidiques, leur procédé de fabrication et leur utilisation pharmaceutique
EP0750635B1 (fr) Peptides pour inhiber la liberation de pepsine
FR2524878A1 (fr) Peptides a activite biologique et medicament les contenant
JPH0320400B2 (ja)
BE885283A (fr) Nouveaux peptides biologiquement actifs et leur emploi comme medicaments